The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-ethyl 6-chloro-3-((2-isobutyrylhydrazono)methyl)-1H-indole-2-carboxylate ID: ALA4554659
PubChem CID: 155556185
Max Phase: Preclinical
Molecular Formula: C16H18ClN3O3
Molecular Weight: 335.79
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1/C=N/NC(=O)C(C)C
Standard InChI: InChI=1S/C16H18ClN3O3/c1-4-23-16(22)14-12(8-18-20-15(21)9(2)3)11-6-5-10(17)7-13(11)19-14/h5-9,19H,4H2,1-3H3,(H,20,21)/b18-8+
Standard InChI Key: XFXPLNKNKSNICH-QGMBQPNBSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
23.6979 -18.1286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6967 -18.9560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4116 -19.3688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4098 -17.7159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1251 -18.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1300 -18.9514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9174 -19.2022 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.3993 -18.5308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9096 -17.8651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9820 -19.3679 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.1599 -17.0790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9658 -16.9027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2162 -16.1167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0221 -15.9404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2724 -15.1543 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.2243 -18.5259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6410 -19.2379 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6326 -17.8090 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4659 -19.2330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8826 -19.9450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5777 -16.5502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3273 -17.3363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3836 -16.3740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 2 0
8 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 1 0
14 21 1 0
21 22 1 0
21 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.79Molecular Weight (Monoisotopic): 335.1037AlogP: 3.10#Rotatable Bonds: 5Polar Surface Area: 83.55Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.97CX Basic pKa: 0.72CX LogP: 3.34CX LogD: 3.33Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.50Np Likeness Score: -1.27
References 1. van der Vlag R, Guo H, Hapko U, Eleftheriadis N, Monjas L, Dekker FJ, Hirsch AKH.. (2019) A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1., 174 [PMID:31026746 ] [10.1016/j.ejmech.2019.04.021 ]